Menu
1 min read · estimated
APPROVED USE
What FDA approved
For advanced ovarian cancer relapsing at least 6 months after platinum with carboplatin; first-line metastatic breast cancer after failed adjuvant anthracycline therapy unless contraindicated, with paclitaxel; first-line inoperable locally advanced or metastatic NSCLC with cisplatin; and locally advanced or metastatic pancreatic adenocarcinoma in first-line use or after prior fluorouracil.
LAMPGEN ANALYSIS
Why it matters
A separate 505(b)(2) gemcitabine injection approval covers four established tumor settings with distinct regimens.
What research teams should watch
Check the exact formulation, vial preparation instructions, and the partner treatment and schedule required for each indication.
PRIMARY RECORDS